CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,195 | -17.9% | 2,824 | -9.1% | 0.05% | -15.0% |
| Q2 2023 | $101,318 | +17.8% | 3,106 | +27.0% | 0.06% | +27.7% |
| Q1 2023 | $86,040 | -44.5% | 2,445 | -27.7% | 0.05% | -42.0% |
| Q4 2022 | $155,009 | +20.2% | 3,383 | +26.9% | 0.08% | +58.8% |
| Q3 2022 | $129,000 | +24.0% | 2,665 | +0.7% | 0.05% | +30.8% |
| Q2 2022 | $104,000 | -32.5% | 2,647 | -36.6% | 0.04% | -43.5% |
| Q1 2022 | $154,000 | -23.8% | 4,176 | -5.6% | 0.07% | -9.2% |
| Q4 2021 | $202,000 | -42.0% | 4,425 | -54.5% | 0.08% | -50.3% |
| Q3 2021 | $348,000 | +71.4% | 9,723 | -5.0% | 0.15% | +84.3% |
| Q2 2021 | $203,000 | -38.3% | 10,237 | -27.6% | 0.08% | -40.3% |
| Q1 2021 | $329,000 | +13.8% | 14,136 | +1.8% | 0.14% | +15.8% |
| Q4 2020 | $289,000 | -7.4% | 13,889 | -3.7% | 0.12% | -26.8% |
| Q3 2020 | $312,000 | -19.2% | 14,417 | -12.0% | 0.16% | -10.4% |
| Q2 2020 | $386,000 | -3.0% | 16,388 | -51.4% | 0.18% | +11.6% |
| Q1 2020 | $398,000 | -2.9% | 33,754 | -12.7% | 0.16% | +144.8% |
| Q4 2019 | $410,000 | +36.2% | 38,686 | +46.1% | 0.07% | +9.8% |
| Q3 2019 | $301,000 | -4.4% | 26,487 | -5.3% | 0.06% | -7.6% |
| Q2 2019 | $315,000 | +15.4% | 27,962 | -17.2% | 0.07% | -88.6% |
| Q1 2019 | $273,000 | +15.2% | 33,758 | -9.9% | 0.58% | +1317.1% |
| Q4 2018 | $237,000 | -51.9% | 37,487 | -25.1% | 0.04% | -19.6% |
| Q3 2018 | $493,000 | -30.9% | 50,077 | -41.7% | 0.05% | -91.9% |
| Q2 2018 | $713,000 | +6.1% | 85,880 | -8.0% | 0.63% | +8.1% |
| Q1 2018 | $672,000 | +93.1% | 93,309 | +118.8% | 0.58% | +33.4% |
| Q4 2017 | $348,000 | +2.7% | 42,645 | +82.3% | 0.44% | +850.0% |
| Q3 2017 | $339,000 | +31.9% | 23,395 | +10.1% | 0.05% | +21.1% |
| Q2 2017 | $257,000 | -19.7% | 21,255 | -14.6% | 0.04% | -33.3% |
| Q1 2017 | $320,000 | +17.2% | 24,879 | +10.6% | 0.06% | -30.5% |
| Q4 2016 | $273,000 | +1.1% | 22,494 | -23.4% | 0.08% | -37.4% |
| Q3 2016 | $270,000 | -3.2% | 29,379 | 0.0% | 0.13% | -36.7% |
| Q2 2016 | $279,000 | +78.8% | 29,379 | +32.8% | 0.21% | -3.7% |
| Q1 2016 | $156,000 | – | 22,124 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |